GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Shiller PE Ratio

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Shiller PE Ratio : 30.13 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-26), Shijiazhuang Yiling Pharmaceutical Co's current share price is ¥18.38. Shijiazhuang Yiling Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.61. Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio for today is 30.13.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:002603' s Shiller PE Ratio Range Over the Past 10 Years
Min: 30.11   Med: 48.54   Max: 106
Current: 30.13

During the past years, Shijiazhuang Yiling Pharmaceutical Co's highest Shiller PE Ratio was 106.00. The lowest was 30.11. And the median was 48.54.

SZSE:002603's Shiller PE Ratio is ranked worse than
61.12% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.25 vs SZSE:002603: 30.13

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shijiazhuang Yiling Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.182. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shijiazhuang Yiling Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Shiller PE Ratio Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 51.30 49.12 56.21 38.86

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.56 41.78 37.68 38.86 33.24

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio falls into.



Shijiazhuang Yiling Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=18.38/0.61
=30.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shijiazhuang Yiling Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Shijiazhuang Yiling Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.182/115.2271*115.2271
=0.182

Current CPI (Mar. 2024) = 115.2271.

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.063 98.200 0.074
201409 0.114 98.900 0.133
201412 0.041 99.000 0.048
201503 0.079 99.900 0.091
201506 0.064 99.500 0.074
201509 0.071 100.500 0.081
201512 0.064 100.600 0.073
201603 0.114 102.200 0.129
201606 0.079 101.400 0.090
201609 0.079 102.400 0.089
201612 0.064 102.600 0.072
201703 0.133 103.200 0.149
201706 0.067 103.100 0.075
201709 0.064 104.100 0.071
201712 0.057 104.500 0.063
201803 0.179 105.300 0.196
201806 0.086 104.900 0.094
201809 0.064 106.600 0.069
201812 0.021 106.500 0.023
201903 0.171 107.700 0.183
201906 0.100 107.700 0.107
201909 0.071 109.800 0.075
201912 0.021 111.200 0.022
202003 0.264 112.300 0.271
202006 0.164 110.400 0.171
202009 0.179 111.700 0.185
202012 0.121 111.500 0.125
202103 0.404 112.662 0.413
202106 0.173 111.769 0.178
202109 0.155 112.215 0.159
202112 0.072 113.108 0.073
202203 0.290 114.335 0.292
202206 0.338 114.558 0.340
202209 0.219 115.339 0.219
202212 0.568 115.116 0.569
202303 0.720 115.116 0.721
202306 0.242 114.558 0.243
202309 0.091 115.339 0.091
202312 -0.243 114.781 -0.244
202403 0.182 115.227 0.182

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shijiazhuang Yiling Pharmaceutical Co  (SZSE:002603) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shijiazhuang Yiling Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Executives
Zhang Qiu Lian Directors, executives
Han Yue Zhi Executives
Zhao Shao Hua Executives
Wang Wei Executives
Gao Xue Dong Supervisors
Wu Yi Ling Director
Gao Xiu Qiang Executives
Wu Xiang Jun Directors, executives
Guo Shuang Geng Director
Wang Hua Securities Affairs Representative
Dai Feng Xiang Directors, executives
Liu Gen Wu Supervisors
Wang Wei Ping Directors, executives
Xu Wei Dong Director
Wu Rui Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines